Personalized medicine, often referred to as precision medicine, represents a transformative approach to healthcare that tailors prevention, diagnosis, and treatment strategies to individual patient characteristics, including genetic, molecular, environmental, and lifestyle factors. Advances in genomics, bioinformatics, artificial intelligence, and biomarker research have accelerated the implementation of personalized medicine across multiple clinical disciplines. This study reviews the clinical outcomes associated with personalized medicine approaches, examining their impact on treatment efficacy, patient safety, disease prevention, and healthcare delivery. Through a comprehensive review of current literature, clinical trials, and case studies, the research highlights significant improvements in therapeutic outcomes, particularly in oncology, cardiology, neurology, and rare genetic disorders. Despite notable successes, challenges remain regarding cost, accessibility, ethical considerations, and integration into routine clinical practice. The study concludes that personalized medicine offers substantial potential to improve healthcare outcomes while emphasizing the need for equitable implementation and robust regulatory frameworks.